As noted in the prospective section of the India Glioblastoma Market Trends Report, the market is poised for significant innovation through personalized medicine and targeted delivery technologies over the next decade.
Future Growth Frontiers
Precision Neuro-Oncology: Tailoring drug combinations based on individual genetic profiling (e.g., IDH-1/2 mutations, EGFR amplification).
Cross-BBB Drug Delivery: Nanotechnology-based drug delivery systems designed to cross the blood-brain barrier effectively.
Immunotherapy & Vaccines: Clinical trials evaluating personalized dendritic cell vaccines and immune checkpoint inhibitors for recurrent glioblastoma cases.
Medical Tourism: India’s emergence as a hub for cost-effective neurosurgical procedures attracting international patients across South Asia and the Middle East.
Explore additional reports to understand evolving market landscapes:
Immunoassay Analyzers Market Outlook
Integrated Cardiology Devices Market Analysis
